The Transatlantic Trade and Investment Partnership (TTIP) aims to create more open trade between the EU and the US. Strengthening the world’s most important trading relationship can serve as a key platform to bring quicker new treatment options to patients. TTIP has the potential to facilitate the development of new medicines and deliver better and faster health outcomes to patients.

Researching and developing medicines is an increasingly collaborative and global process: pharmaceutical companies, academic institutions and healthcare systems from all over the world work together to develop new and innovative medicines. By reducing the need to do things twice, TTIP can help them stimulate, drive and deliver the treatments that patients need, not only in Europe and the US but also worldwide.